Grifols SA - ADR - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
GRFS Nasdaq 2836 https://www.grifols.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Grifols SA - ADR

Are Investors Undervaluing Grifols (GRFS) Right Now? - Mar 15th, 2023 1:40 pm
Grifols (GRFS) Upgraded to Strong Buy: Here's Why - Mar 7th, 2023 5:00 pm
Selagine Enters into a Collaborative Agreement with Grifols for Development and Commercialization of Immunoglobulin Eye Drops for Treating Dry Eye Disease - Mar 6th, 2023 12:00 pm
UPDATE 2-Grifols' shares tank 10% as 2023 outlook disappoints - Feb 28th, 2023 8:23 am
Is Grifols (GRFS) Stock Undervalued Right Now? - Feb 27th, 2023 2:40 pm
Spanish drug company with Bay Area operations to shed 2,300 jobs - Feb 17th, 2023 10:07 pm
Grifols to lay off 8.5% of workforce under $427 mln savings plan - Feb 15th, 2023 5:22 pm
Is Grifols (GRFS) a Great Value Stock Right Now? - Feb 10th, 2023 2:40 pm
Grifols considers selling 2 bln euros worth of assets to cut debt, Cinco Dias says - Dec 14th, 2022 9:00 am
Grifols receives FDA clearance for AlphaID™ At Home, the first free service for U.S. consumers to determine their risk for alpha-1 - Nov 3rd, 2022 1:00 pm
10 Best Pharma Stocks To Buy Now - Oct 24th, 2022 2:13 pm
Grifols says U.S. blood donors' lawsuit won't have material impact, shares down - Oct 21st, 2022 12:09 pm
10 Best Low Price Pharma Stocks To Buy Now - Oct 18th, 2022 1:03 pm
Grifols appoints executive chairman as seeks to speed recovery - Oct 3rd, 2022 6:05 pm
Victor Grifols Roura decides to retire as Chairperson; Grifols appoints private equity veteran Steven F. Mayer as Executive Chairperson - Oct 3rd, 2022 4:52 pm
GigaGen Awarded Contract by U.S. Department of Defense to Discover Synthetic Human Antibody Treatments for High-Priority Toxins and Pathogens - Sep 15th, 2022 2:29 pm
Grifols enters into agreement with Canadian Blood Services to accelerate self-sufficiency in immunoglobulins for Canada - Sep 7th, 2022 4:06 pm
10 Best Medical Stocks Under $10 - Aug 6th, 2022 12:10 pm
Grifols Procleix Plasmodium Assay receives CE mark, a first for malaria blood screening - Jun 8th, 2022 9:00 am
Got $20? These 3 Healthcare Stocks Could Be Bargain Buys for 2022 and Beyond - May 26th, 2022 12:05 pm